Obesity is a serious health issue that increases the risk of developing diabetes and increases the risk of diabetic kidney ...

In people with type 2 diabetes in the world's richest countries, deaths from cardiovascular disease are declining while ...

University of Chicago researchers developed an mRNA nanoparticle system that triggers cells to produce PD-L1 protein, ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

First new drug in 30 years to slow kidney disease in type 1 diabetes ...

Now, researchers at UBC Okanagan say saliva may offer a much simpler way to spot that risk. Their study suggests that a saliva test can reflect insulin patterns linked to metabolic health, opening the ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of these cells destabilizes the body's glucose levels and drives the course of ...

Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy.

Share on Pinterest A new study suggests that a large percentage of people with diabetes are unaware they have the disease. Justin Paget/Getty Images Researchers estimate that around 44% of people in ...

Kidney disease develops silently. Many people remain unaware of the problem until significant damage has already occurred ...

Diabetes is one of the leading causes of kidney failure. It damages the kidneys through a slow, progressive process that primarily targets the organs' delicate filtering systems.